Addition/Correction pubs.acs.org/jmc
Correction to Discovery of 2‑Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV‑1 Integrase Strand Transfer Inhibitors Izzat T. Raheem,* Abbas M. Walji,* Daniel Klein, John M. Sanders, David A. Powell, Pravien Abeywickrema, Guillaume Barbe, Amrith Bennet, Karla Childers, Melodie Christensen, Sophie−Dorothee Clas, David Dubost, Mark Embrey, Jay Grobler, Michael J. Hafey, Timothy J. Hartingh, Daria J. Hazuda, Jeffrey T. Kuethe, Jamie McCabe Dunn, Michael D. Miller, Keith P. Moore, Andrew Nolting, Natasa Pajkovic, Sangita Patel, Zuihui Peng, Vanessa Rada, Paul Rearden, John D. Schreier, John Sisko, Thomas G. Steele, Jean-François Truchon, John Wai, Min Xu, and Paul J. Coleman Journal of Medicinal Chemistry 2015, 58, 8154−8165. DOI: 10.1021/acs.jmedchem.5b01037 The following coauthors should be included in the author byline (complete author byline is as listed above): Karla Childers, Melodie Christensen, Jeffrey T. Kuethe, Jamie McCabe Dunn, Andrew Nolting, and Zuihui Peng These authors are affiliated with Department of Process Chemistry, Merck & Co., Inc., Rahway, NJ 07065. The title of Scheme 3 should be: Scheme 3. Synthesis of Tris-Pivaloylated Intermediate 1430 to indicate the additional citation for the reference added below: (30) Barbe, G. HIV Integrase Inhibitors. U.S. Patent Application WO/2012/058173, May 12, 2012. Coleman, P. J. Substituted Naphthyridinedione Derivatives as HIV Integrase Inhibitors. U.S. Patent Application WO/2014/018449, Jan 30, 2014.
Published: December 28, 2015 © 2015 American Chemical Society
486
DOI: 10.1021/acs.jmedchem.5b01957 J. Med. Chem. 2016, 59, 486−486
